Gout. Mechanisms of inflammation in gout

被引:0
|
作者
Nathalie Busso
Alexander So
机构
[1] Centre Hospitalier Universitaire Vaudois,Service de Rheumatologie
[2] Université de Lausanne,undefined
关键词
Gout; NLRP3 Inflammasome; Acute Gout; Urate Crystal; Acute Gouty Arthritis;
D O I
暂无
中图分类号
学科分类号
摘要
An acute attack of gout is a paradigm of acute sterile inflammation, as opposed to pyogenic inflammation. Recent studies suggest that the triggering of IL-1β release from leucocytes lies at the heart of a cascade of processes that involves multiple cytokines and mediators. The NLRP3 inflammasome appears to have a specific role in this regard, but the biochemical events leading to its activation are still not well understood. We review the known mechanisms that underlie the inflammatory process triggered by urate crystals and suggest areas that require further research.
引用
收藏
相关论文
共 50 条
  • [41] Gout. New opportunities of diagnosis and treatment
    Yakupova, S. P.
    TERAPEVTICHESKII ARKHIV, 2018, 90 (05) : 88 - 92
  • [42] Quality of care for veterans with diagnosis of gout.
    Singh, JA
    Nelson, DB
    Toscano, J
    Hodges, J
    Thomas, J
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S410 - S410
  • [43] Lost days and productivity impact of gout.
    Kleinman, NL
    Patel, PA
    Brook, R
    Melkonian, AK
    Smeeding, JE
    Joseph-Ridge, N
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S657 - S657
  • [44] Increased prevalence of subclinical hypothyroidism in gout.
    Munn, EJ
    Alloway, JA
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S152 - S152
  • [45] Local sepsis as a factor in rheumatism and gout.
    Wirgman, CW
    Turner, HW
    LANCET, 1909, 2 : 1665 - 1668
  • [46] Severe morbidity associated with refractory gout.
    Sundy, JS
    Hershfield, MS
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S140 - S140
  • [47] Aim for Better Gout Control: A Retrospective Analysis of Preventable Hospital Admissions for Gout.
    Sharma, Tarun S.
    Harrington, Thomas M.
    Olenginski, Thomas P.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1014 - S1014
  • [48] Febuxostat a new drug for treatment of gout. Increased cardiovascular risk in gout patients?
    Christalla, P.
    Wittkoepper, K.
    El-Armouche, A.
    KARDIOLOGE, 2011, 5 (01): : 45 - 49
  • [49] INFLAMMASOME GENES POLYMORPHISMS AND SUSCEPTIBILITY TO GOUT. IS THERE A LINK?
    Clavijo-Cornejo, Denise
    Lopez-Reyes, Alberto
    Cruz-Arenas, Esteban
    Jacobo-Albavera, Leonor
    Rivera-Tlaltzicapa, Daniel
    Francisco-Balderas, Adriana
    Dominguez-Perez, Mayra
    Romero-Morelos, Pablo
    Vazquez-Mellado, Janitzia
    Silveira, Luis H.
    Pineda, Carlos
    Martinez-Nava, Gabriela
    Gutierrez, Marwin
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2022, 74 (03): : 147 - 155
  • [50] IMAGING IN THE MANAGEMENT OF GOUT. CLINICAL TOOL OR ENDPOINT?
    Dalbeth, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 20 - 20